Woodline Partners LP Celldex Therapeutics, Inc. Transaction History

Woodline Partners LP

$19.5 Billion
Q3 2025

A detailed history of Woodline Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 199,291 shares of CLDX stock, worth $5.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

199,291

Previous 1,500,455 86.72%

Holding current value

$5.09 Million

Previous $30.5 Million 83.12%

% of portfolio

0.03%

Previous 0.17%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$20.01 - $26.19 $26 Million - $34.1 Million	-1,301,164 Reduced 86.72%	199,291 $5.16 Million
Q2 2025 Aug 14, 2025	BUY	$15.13 - $21.65 $4.72 Million - $6.76 Million	312,026 Added 26.26%	1,500,455 $30.5 Million
Q1 2025 May 15, 2025	SELL	$18.15 - $27.6 $15 Million - $22.8 Million	-825,586 Reduced 40.99%	1,188,429 $21.6 Million
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $7.62 Million - $10.6 Million	-327,106 Reduced 13.97%	2,014,015 $50.9 Million
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $50.8 Million - $70.6 Million	1,583,350 Added 208.95%	2,341,121 $79.5 Million

Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $219,852 - $285,620	6,711 Added 0.89%	757,771 $28 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $12.8 Million - $18.9 Million	363,408 Added 93.75%	751,060 $31.5 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $6.33 Million - $11.4 Million	280,156 Added 260.62%	387,652 $15.4 Million
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $1.35 Million - $1.99 Million	52,997 Added 97.24%	107,496 $2.96 Million
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $29,441 - $37,208	-972 Reduced 1.75%	54,499 $1.85 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $1.93 Million - $2.63 Million	55,471 New	55,471 $2 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $10.6 Million - $19.2 Million	-514,738 Reduced 88.87%	64,454 $1.74 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $8.83 Million - $12.6 Million	319,297 Added 122.86%	579,192 $19.7 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $9.27 Million - $14.6 Million	259,895 New	259,895 $10 Million

Others Institutions Holding CLDX

# of Institutions

204

Shares Held

66.8M

Call Options Held

222K

Put Options Held

234K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.2B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Celldex Therapeutics, Inc. Transaction History